Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2024-03-22 Declaration of Voting R…
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement titled '정기주주총회결과' (Annual General Meeting Results) for the company '하이텍팜'. It details the outcomes of the meeting, including the approval of financial statements, dividend resolutions, director appointments, and other agenda items. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific executives (CEO, Managing Director, etc.), including the number of shares, exercise price, and vesting period. This type of disclosure regarding capital structure changes and executive compensation via stock options falls under the category of 'Regulatory Filings' (RNS) as it is a specific corporate disclosure required by the exchange that does not fit into the other specialized categories like 'Director's Dealing' (which is for personal trades) or 'Remuneration Information' (which is typically for annual compensation reports).
2024-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Hitech Pharm) titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion, key financial data, and confirmation of the audit completion date. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and filing of the audit report, rather than the full annual report document itself. Therefore, it falls under the category of Audit Report / Information. FY 2023
2024-03-14 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 26th fiscal year (2023) of HT Pharm Co., Ltd. It contains comprehensive information including company overview, business activities, financial data, management details, and research and development activities. This is a standard annual regulatory filing required by the Financial Supervisory Service and the Korea Exchange in South Korea, which corresponds to the 10-K filing type in the provided schema. FY 2023
2024-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for the 26th Annual General Meeting of Hitech Pharm. It contains the meeting agenda, details on board appointments, financial statements (balance sheet and income statement), and information regarding shareholder rights and voting procedures. This type of document is standard for providing shareholders with the necessary information to vote at an AGM, which falls under the Proxy Solicitation & Information Statement category.
2024-03-07 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Hitech Pharm. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and dividend proposals. This document serves as a proxy solicitation or notice of meeting materials provided to shareholders to inform them of the upcoming vote.
2024-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.